Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) – Global Trends & Forecast to 2018

Publisher Name :
Date: 17-Dec-2013
No. of pages: 258
Inquire Before Buying

The global microfluidicsmarket is valued at an estimated $1.59 billion in 2013 and is expected to grow at a CAGR of 17.6% in the next five years.

The global microfluidics marketis categorized into materials, products, and applications segments. This report studies the market trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices.Based on materials, the market is classified into polymers, silicon, glass, and other materials. Based on products, the pharmaceutical market is categorized into microfluidic chips for lab analytics, accurate dispensing devices, and microreactors for drug synthesis. The in-vitro diagnostics segment is further segmented into clinical diagnostics, Point-of-Care, environmental testing, industrial testing, and agro food testing. The drug delivery devices market is categorized into inhaler nozzles, micro needles, and micro pumps.

The rising demand for POC diagnostic devices, quick return on investments offered by microfluidics devices which helps in cost reductions, and miniaturization of microfluidic chips will be the major drivers for this market.However, factors such as difficulty in incorporatingemerging microfluidic technologies into existing workflows and presence of complex and time consuming regulatory standards are hampering the market growth. Recent developments in drug delivery technologies such as microfluidic micropumps and microneedles are encouraging the growth of the microfluidics market. The in-vitro diagnostics segment commands the largest share of the microfluidics products market in 2013. However, the drug delivery devices segment is estimated to grow at the highestCAGR of 24.5% during the study period.

Factors such as reduced costs, driven by the low sample consumption, are demanding the adoption of microfluidic micropumps. The enhanced efficacy of transdermal delivery of macromolecules for treating various diseasesis a major factor driving the growth of themicroneedles market.The breakthrough discovery of injecting macromolecules transdermally is in turn favoring the growth of the API (Active Pharmaceutical Ingredient) market, which is boosting the adoption rate of microneedles.

Major players in the microfluidics market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Caliper Life Sciences (PerkinElmer) (U.S.), Cepheid (U.S.), DanaherCorporation (U.S.), Life Technologies Corporation (U.S.), and Roche Diagnostics (Germany). A majority of companies in the microfluidics market are from the U.S.

Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) – Global Trends & Forecast to 2018

Table Of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Key Data Points From Primary Sources
1.6.4 Key Data Points From Secondary Sources
1.6.5 Assumptions

2 Executive Summary

3 Premium Insights
3.1 Global Microfluidics Market, A Snapshot (2013)
3.2 Market Dynamics
3.3 Microfluidics Market, By Industry
3.4 Microfluidics Market, By Applications
3.5 Geographic Analysis & Materials Market

4 Market Overview
4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Drivers
4.3.1.1 Rising Demand for Point-of-Care (Poc) Testing to Drive the Market
4.3.1.2 Quick Return  on Investments Helping In Cost Reductions
4.3.1.3 Microfluidic Chips Miniaturization Helps to Reduce Testing Time And Cost
4.3.2 Restraints
4.3.2.1 the Incorporation of Emerging Microfluidic Technology Into Existing Workflows Is Challenging
4.3.2.2 Complex And Time Consuming Regulatory Standards to Lengthen the Approval Process
4.3.3 Opportunities
4.3.3.1 Growing Asian Market
4.3.3.2 Shifting Trend towards Polymers Adoption
4.3.3.3 Expanding Applications of Drug Delivery Technologies
4.3.4 Trends
4.3.4.1 Increasing Number of Patent Applications
4.3.5 Challenges for Manufacturers
4.3.5.1 Geometrical Issues
4.3.5.2 Surface Chemistry Issues
4.3.6 Winning Imperatives
4.3.6.1 Standardization
4.3.6.2 Compatibility
4.4 Strategic Benchmarking
4.4.1 Technology Integration & Product Enhancement
4.4.1.1 Collaboration Between Fluidigm Corporation And Olink Bioscience
4.4.1.2 Agreement Between Agilent Technologies, Inc. And Caliper Life Sciences, Inc.
4.4.1.3 Agreement Between Perkinelmer And Genmark Diagnostics, Inc.
4.4.1.4 Collaboration Between Roche Diagnostics And Immatics Biotechnologies GMBH
4.4.1.5 Agreement Between Raindance Technologies And Myriad Genetics, Inc.

5 Microfluidics Market, By Material
5.1 Introduction
5.2 Polymer-Based Microfluidics
5.3 Glass-Based Microfluidics
5.4 Silicon-Based Microfluidics
5.5 Other Materials-Based (Paper & Ceramics) Microfluidics

6 Microfluidic Devices Market, By Industry
6.1 Introduction
6.2 Pharmaceuticals
6.2.1 Microfluidic Chips for Lab Analytics
6.2.1.1 Toxicity Screening
6.2.1.2 Proteomic Analysis
6.2.1.3 Gene Sequencing
6.2.1.4 Capillary Electrophoresis
6.2.2 Accurate Dispensing Devices
6.2.3 Microreactors for Drug Synthesis
6.3 In-Vitro Diagnostics
6.3.1 Clinical Diagnostics
6.3.2 Point-of-Care (Poc)
6.3.3 Environmental Testing
6.3.4 Industrial Testing
6.3.5 Agro Food Testing
6.4 Drug Delivery Devices
6.4.1 Inhaler Nozzles
6.4.2 Microneedles
6.4.3 Micropumps

7 Microfluidics Devices Market, By Applications
7.1 Introduction
7.2 Drug Delivery
7.3 Industrial & Environmental
7.4 Analysis (Toxicity Screening, Proteomic Analysis & Gene Sequencing)
7.5 Pharmaceutical & Life Science Research
7.6 Point of Care Diagnostics
7.7 Clinical & Veterinary Diagnostics

8 Geographic Analysis
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia
8.5 Rest of the World (ROW)

9 Competitive Landscape
9.1 Introduction
9.2 Mergers & Acquisitions
9.3 Agreements, Partnerships, Collaborations, & Joint Ventures
9.4 New Product Launches
9.5 Expansion
9.6 Approvals

10 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*
10.1 Abbott Laboratories, Inc.
10.2 Agilent Technologies
10.3 Perkinelmer, Inc.
10.4 Bartels Mikrotechnik GMBH
10.5 Scienion AG
10.6 Cepheid, Inc.
10.7 Fluidigm Corporation
10.8 Raindance Technologies
10.9 Becton, Dickinson And Company 1 Becton Drive
10.10 Bio-Rad Laboratories, Inc.
10.11 Biofluidix GMBH
10.12 Danaher Corporation
10.13 Johnson & Johnson
10.14 Life Technologies Corporation
10.15 Microfluidic Chipshop GMBH
10.16 Roche Diagnostics Limited
10.17 Siemens Healthcare

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

Competitive Developments (2011-2013)

List of Tables

Table 1 Global Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 2 Global Microfluidic Materials Market: Revenue, By Type, 2011-2018 ($Million)
Table 3 Microfluidic Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 4 Polymer-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 5 Glass-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 6 Silicon-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 7 Paper & Ceramics-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 8 Microfluidics Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 9 Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 10 Microfluidics Pharmaceutical Products Market Revenue, By Geography, 2011-2018 ($Million)
Table 11 Microfluidic Chips for Lab Analytics Market Revenue, By Products, 2011-2018 ($Million)
Table 12 Microfluidic Chips for Lab Analytics Market Revenue, By Geography, 2011-2018 ($Million)
Table 13 Microfluidic Chips for Toxicity Screening Market Revenue, By Geography, 2011-2018 ($Million)
Table 14 Microfluidic Chips for Proteomic Analysis Market Revenue, By Geography, 2011-2018 ($Million)
Table 15 Microfluidic Chips for Gene Sequencing Market Revenue, By Geography, 2011-2018 ($Million)
Table 16 Microfluidic Chips for Capillary Electrophoresis Market Revenue, By Geography, 2011-2018 ($Million)
Table 17 Microfluidic Accurate Dispensing Devices Market Revenue, By Geography, 2011-2018 ($Million)
Table 18 Microfluidic Microreactors for Drug Synthesis Market Revenue, By Geography, 2011-2018 ($Million)
Table 19 Microfluidic In-Vitro Diagnostics Market Revenue, By Products, 2011-2018 ($Million)
Table 20 Microfluidic In-Vitro Diagnostics Market Revenue, By Geography, 2011-2018 ($Million)
Table 21 Microfluidic Clinical Diagnostics Market Revenue, By Geography, 2011-2018 ($Million)
Table 22 Microfluidics Point of Care Market Revenue, By Geography, 2011-2018 ($Million)
Table 23 Microfluidic Environmental Testing Market Revenue, By Geography, 2011-2018 ($Million)
Table 24 Microfluidic Industrial Testing Market Revenue, By Geography, 2011-2018 ($Million)
Table 25 Microfluidic Agro Food Testing Market Revenue, By Geography, 2011-2018 ($Million)
Table 26 Microfluidic Drug Delivery Devices Market Revenue, By Products, 2011-2018 ($Million)
Table 27 Microfluidic Drug Delivery Devices Market Revenue, By Geography, 2011-2018 ($Million)
Table 28 Microfluidic Inhaler Nozzles Market Revenue, By Geography, 2011-2018 ($Million)
Table 29 Microfluidic Microneedles Market Revenue, By Geography, 2011-2018 ($Million)
Table 30 Microfluidic Micropumps Market Revenue, By Geography, 2011-2018 ($Million)
Table 31 Global Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 32 Microfluidics Drug Delivery Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 33 Microfluidics Industrial & Environmental Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 34 Microfluidics Analysis Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 35 Microfluidics Pharmaceutical & Life Science Research Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 36 Microfluidics Point of Care Diagnostics Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 37 Microfluidics Clinical & Veterinary Diagnostics Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 38 Global Microfluidics Market Revenue, By Geography, 2011-2018 ($Million)
Table 39 North America: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 40 North America: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 41 North America: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 42 North America: Microfluidic Chips for Lab Analytics Market Revenue, By Product, 2011-2018 ($Million)
Table 43 North America: Microfluidics Ivd Market Revenue, By Product, 2011-2018 ($Million)
Table 44 North America: Microfluidic Drug Delivery Devices Market Revenue, By Products, 2011-2018 ($Million)
Table 45 North America: Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 46 Europe: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 47 Europe: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 48 Europe: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 49 Europe: Microfluidic Chips for Lab Analytics Market Revenue, By Products, 2011-2018 ($Million)
Table 50 Europe: Microfluidics Ivd Market Revenue, By Products, 2011-2018 ($Million)
Table 51 Europe: Microfluidics Drug Delivery Devices Market Revenue, By Products, 2011-2018 ($Million)
Table 52 Europe: Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 53 Asia: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 54 Asia: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 55 Asia: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 56 Asia: Microfluidics Chips for Lab Analytics Market Revenue, By Products, 2011-2018 ($Million)
Table 57 Asia: Microfluidics Ivd Market Revenue, By Products, 2011-2018 ($Million)
Table 58 Asia: Microfluidics Drug Delivery Devices Market Revenue, By Product, 2011-2018 ($Million)
Table 59 Asia: Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 60 ROW: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 61 ROW: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 62 ROW: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 63 ROW: Microfluidic Chips for Lab Analytics Market Revenue, By Product, 2011-2018 ($Million)
Table 64 ROW: Microfluidics Ivd Market Revenue, By Product, 2011-2018 ($Million)
Table 65 ROW: Microfluidics Drug Delivery Devices Market Revenue, By Product, 2011-2018 ($Million)
Table 66 ROW: Microfluidic Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 67 Mergers & Acquisitions, 2011-2013
Table 68 Agreements, Partnerships, Collaborations, & Joint Ventures, 2011-2013
Table 69 New Product Launches, 2011-2013
Table 70 Expansion, 2011-2012
Table 71 Approvals, 2013
Table 72 Life Technologies Corporation: Total Revenue, By Segment, 2010-2012 ($Million)

List of Figures

Figure 1 Market Crackdown & Data Triangulation Methodology for Microfluidics Market
Figure 2 Market forecasting Model
Figure 3 Research Output: 360o Validation
Figure 4 Global Microfluidics Market, By Products, 2013-2018 ($Million)
Figure 5 Global Microfluidics Market, 2013
Figure 6 Microfluidics Market Dynamics
Figure 7 Microfluidics Market, By Industry, 2013-2018
Figure 8 Microfluidics Market, By Applications, 2013 Vs 2018
Figure 9 Microfluidics Market: Geographic Analysis, 2013 ($Million)
Figure 10 Microfluidics Market Segmentation
Figure 11 Technology Adoption & Product Enhancement
Figure 12 Microfluidics Market: By Materials, 2011-2018 (Market Size & Growth Rates)
Figure 13 Global Polymers Market Comparison, 2013 Vs 2018
Figure 14 Microfluidics Market, By Products, 2013-2018
Figure 15 Microfluidics Products Market Revenue, By Industry – A Focus on Ivd (2013)
Figure 16 Global Microfluidics Market, By Applications, 2013-2018
Figure 17 Opportunity Matrix: Microfluidics Market, By Geography, 2013-2018
Figure 18 Key Growth Strategies in Microfluidics Market, 2011-2013
Figure 19 Abbott Laboratories, Inc.: Total Revenue And R&D Expenses, 2010-2012 ($Billion)
Figure 20 Abbott Laboratories, Inc.: Geographic Revenue Mix, 2012
Figure 21 Abbott Laboratories, Inc.: Business Revenue Mix, 2012
Figure 22 Abbott Laboratories, Inc.: Market Strategy, 2011-2013
Figure 23 Agilent Technologies: Total Revenue And R&D Expenses, 2010-2012 ($Billion)
Figure 24 Agilent Technologies: Business Revenue Mix, 2012
Figure 25 Agilent Technologies: Market Strategy, 2010-2012
Figure 26 Perkinelmer, Inc.: Total Revenue And R&D Expenses, 2010-2012 ($Billion)
Figure 27 Perkinelmer, Inc.: Geographic Revenue Mix, 2012
Figure 28 Perkinelmer, Inc.: Business Revenue Mix, 2012
Figure 29 Perkinelmer, Inc.: Market Strategy, 2011-2012
Figure 30 Scienion AG: Market Strategy, 2012-2013
Figure 31 Cepheid, Inc.: Total Revenue And R&D Expenses, 2010-2012 ($Million)
Figure 32 Cepheid, Inc.: Geographic Revenue Mix, 2012
Figure 33 Cepheid, Inc.: Business Revenue Mix, 2012
Figure 34 Cepheid, Inc.: Market Strategy, 2011-2013
Figure 35 Fluidigm Corporation: Total Revenue And R&D Expenses, 2010-2012 ($Million)
Figure 36 Fluidigm Corporation: Geographic Revenue Mix, 2012
Figure 37 Fluidigm Corporation: Business Revenue Mix, 2012
Figure 38 Fluidigm Corporation: Market Strategy, 2011-2013
Figure 39 Raindance Technologies: Market Strategy, 2011-2013
Figure 40 Becton, Dickinson And Company: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 41 BD Diagnostics: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 42 Becton, Dickinson And Company: Market Strategy, 2011-2013
Figure 43 Bio-Rad Laboratories, Inc.: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 44 Bio-Rad Laboratories, Inc.: Market Srategy, 2011-2013
Figure 45 Danaher Corporation: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 46 Danaher Corporation: Market Strategy, 2011-2013
Figure 47 Johnson & Johnson: Total Revenue, By Segment, 2010-2012 ($Milllion)
Figure 48 Johnson & Johnson: Diagnostics Franchise Revenue, 2010-2012 ($Million)
Figure 49 Johnson & Johnson: Market Strategy, 2011-2013
Figure 50 Life Technologies Corporation: Market Strategy, 2012-2013
Figure 51 Roche Holdings: Diagnostics Revenue, By Segment, 2010-2012 ($Million)
Figure 52 Roche Holdings: Diagnostics Revenue, By Geography, 2010-2012 ($Million)
Figure 53 Roche Holdings: Market Strategy, 2011-2013
Figure 54 Siemens Ag: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 55 Siemens Healthcare: Market Strategy, 2011-2013

  • Overcoming Obesity
    In today’s world where there are countries struggling to overcome famine and shortage of food there are others who are increasingly getting populated with obese people. Obesity is one of the key problem many are facing across the world. It is a result of either improper lifestyle and food habits or is completely hereditary. In [...]
  • The Booming Market of Carbon Fibre
    The speed at which the Carbon Fibre Industry is growing it is sure to be one of the most profitable industry in the years to come. The sales of carbon fibre tow is expected to increase from $1.6 billion in 2011 to $4.5 billion in 2020. The overall The global demand for carbon fibre tow [...]
  • Incentivising Research & Development Activities
    Research and Development (R&D) is the base of innovation, competitiveness and economic performance. Any company or a country that seeks to be ahead of its competitors need to invest heavily in setting up an active R&D wing. In today’s world everything is technology oriented.  People are coming up with new ideas, products and newer ways [...]
  • Global Cystic Fibrosis Market Propelled by Technological Advancement
    With increasing prevalence of cystic fibrosis and its growing awareness among people, the global market for cystic fibrosis is expected to grow at a steady pace. Cystic fibrosis is a genetic condition where the lungs and digestive system becomes clogged with excess mucus. This condition is more common among Caucasian population than people of Asian [...]
  • Bright Prospects Ahead for the SONAR Systems and Technology Market
    With advancement of technology, the global SONAR systems and technology market is increasing at a rapid pace. SONAR which is an acronym for SOund Navigation And Ranging is a technique that uses sound propagation to navigate and communicate with objects on or under the surface of the water, such as other vessels. In 2014, the [...]
  • The Boom In Women Infertility Market
  • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Retaining the Hard-Won Consumers
  • With the increase in mobile phone usage different operators are coming up with different plan in order to cater to users of all age-group with various data plan to choose from. With the maturing mobile market operators are coming up …

  • To bring in Photography to the Real World Visual Supply Co Acquires Artifact Uprising
  • Visual Supply Co, VSCO has brought a Denver-based startup, Artifact Uprising, which is focused on bringing photographers’ work from the digital hubs on regular basis by modern creatives to the real world as prints and tangible books. Artifact Uprising is …

  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) – Global Forecast to 2019
    Published: 26-Mar-2015        Price: US $4650 Onwards        Pages: 210
    The global pharmacovigilance and drug safety software market is expected to grow at a CAGR of 6.5% from 2014 to 2019. North America region held the largest share of the pharmacovigilance and drug safety software market in 2014. However, Asian and Latin American countries symbolize high growth markets. This is owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations. The growth of the global ......
  • Tumor Ablation Market by Procedure Volume, Technology (RF, Microwave, Cryoablation, Others), Department (Interventional Radiology, Surgery, Oncology), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis) – Global Forecasts to 2019
    Published: 26-Mar-2015        Price: US $4650 Onwards        Pages: 195
    The global tumor ablation market is poised to grow at a CAGR of 11.5% during 2014-2019, and is expected to reach a value of ~462.0 Million in 2019. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the tumor ablation market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period.The growth of the tumor ablation market is driven by factors such as growing geriatric population, coupled with an increasing population base ......
  • Rehabilitation Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
    Published: 26-Mar-2015        Price: US $4000 Onwards        Pages: 659
    WinterGreen Research announces that it has published a new study Rehabilitation Robots:  Market Shares, Strategy, and Forecasts, Worldwide, 2014 to 2020.  The 2015 study has 659 pages, 266 tables and figures.  Worldwide markets are poised to achieve significant growth as the rehabilitation robots, active prostheses, and exoskeletons are used inside rehabilitation treatment centers and sports facilities providing rehabilitation for all patients with injuries or physical dysfunction. Relearn......
  • Transplant Diagnostics Market by Technology (Serological, MLC, PCR, NGS), Antigen (HLA Class I & II), Product (Instrument, Reagent, Kits), Application (Diagnostic, Research), End User (Hospitals, Diagnostic Centers, Academia) – Global Forecasts to 2019
    Published: 25-Mar-2015        Price: US $4650 Onwards        Pages: 180
    The global transplant diagnostics market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of ~645.0 Million in 2019. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the transplant diagnostics market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period.The growth of the transplant diagnostics market is driven by factors such as growing geriatric population,coupled with an incre......
  • Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Stomach, Small Intestine, Large Intestine) & Geography – Global Forecast to 2024
    Published: 25-Mar-2015        Price: US $4650 Onwards        Pages: 200
    The healthcare industry is witnessing a paradigm shift from traditional devices to more sophisticated and programmed ones. Growing demand for noninvasive procedures, sophisticated drug delivery techniques, and improved patient monitoring solutions are propelling the growth of this market. Companies are increasingly focusing on investing in R&D activities for the development of the smart pills technology in order to meet consumer expectations and to help in the treatment of various diseases. ......
  • Oncology Information System Market by Software (Patient Information System & TPS), & Professional Service), Application (Medical, Radiation, & Surgical Oncology), End User (Hospital, Government Institution, & Research Center) – Global Forecasts to 2019
    Published: 25-Mar-2015        Price: US $4650 Onwards        Pages: 210
    The global oncology information system market is estimated to growata CAGR of 8.5% from 2014 to 2019. Although mature markets such as the U.S., the U.K., and Germany hold larger shares in the oncology information system market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 11.5% in the next five years.Factors such as increasing government initiatives for modernization of healthcare infrastructure, growing patient population, and rising focus of international and domest......
  • Foley Catheters Market – Global Market Outlook 2015-2019
    Published: 25-Mar-2015        Price: US $3000 Onwards        Pages: 106
    What is Foley Catheter? A Foley catheter, also called an indwelling catheter, is inserted into the bladder to drain urine. It comprises a balloon that holds the catheter in the bladder at one end.  The balloon is filled with sterile water to prevent the catheter from being removed from the bladder. The urine is drained through the catheter tube into a collection bag. Foley catheters are used for extended periods of time, such as for weeks or a month.  These catheters are used after urologic......
  • Global Hip Implant Market 2015-2019
    Published: 25-Mar-2015        Price: US $2500 Onwards        Pages: 81
    Hip replacement is an orthopedic surgical procedure in which the damaged hip joint is replaced with an artificial joint. An artificial joint usually made from metal, ceramic, or polymeric components. The surgery is performed either by traditional technique or by minimally invasive technique. The hip replacement surgery is generally performed in patients to relieve them from arthritis pain or hip fracture. Hip replacement surgery can be total hip replacement (replacing the entire hip), partial re......
  • Global Intermittent Catheters Market 2015-2019
    Published: 25-Mar-2015        Price: US $3000 Onwards        Pages: 111
    Intermittent catheters are used for emptying the urinary bladder in patients who lose control over their bladder. These catheters are used for short term. Urine incontinence can be caused due to neurogenic bladder disorders such as spinal cord injury, spina bifida or multiple sclerosis, and non-neurogenic bladder disorders. The catheter is inserted into the urethra and guided to the bladder causing the urine to flow through the catheter tube and drain into the collection bag. Once the bladder is......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs